{"hands_on_practices": [{"introduction": "The central challenge in managing crateriform skin lesions is the histopathological distinction between keratoacanthoma (KA) and squamous cell carcinoma (SCC). This exercise simulates that diagnostic crossroads, tasking you with applying foundational principles to identify unequivocal histologic features of malignancy that are essential for accurate risk assessment and treatment planning.", "problem": "A dermatologist evaluates a rapidly growing, crateriform nodule on the dorsal forearm of a patient aged $72$ years with chronic ultraviolet exposure. Shave biopsy reveals a cup-shaped epidermal invagination filled with compact keratin, flanked by lips of acanthotic squamous epithelium. The dermal component shows well-differentiated squamous lobules with abundant keratinization. There is debate about whether the lesion represents Keratoacanthoma (KA) or conventional Squamous Cell Carcinoma (SCC). Starting from the fundamental histopathological principles that define malignancy in cutaneous squamous neoplasms—namely, invasive growth beyond normal tissue planes, high-grade cytologic atypia with atypical mitoses, and invasion of neurovascular structures—identify which features, if present in a crateriform tumor, mandate a diagnosis of conventional SCC rather than KA. Select all that apply.\n\nOptions:\n\nA. Symmetric crateriform architecture with central keratin plug and broad pushing borders confined to the upper dermis\n\nB. Irregular infiltrative tongues and strands of atypical squamous cells extending into deep dermis or subcutis, accompanied by a desmoplastic stromal response\n\nC. Marked cytologic atypia with numerous atypical mitoses and foci of tumor necrosis within invasive nests\n\nD. Perineural invasion (tumor cells tracking along or within nerve sheaths) by atypical squamous nests\n\nE. Intraepidermal neutrophils and focal microabscesses within the keratin plug, with otherwise well-circumscribed architecture\n\nF. Abrupt keratinization with “glassy” eosinophilic cytoplasm in a well-demarcated lesion limited to the upper dermis\n\nG. Lymphovascular invasion (tumor cells within endothelial-lined spaces) by malignant squamous cells\n\nH. Clinical course of rapid growth followed by partial spontaneous regression and fibrosis at the lesion base without high-grade atypia or invasion", "solution": "The problem asks to identify histopathological features that, if present in a crateriform squamous proliferation, would mandate a diagnosis of conventional Squamous Cell Carcinoma (SCC) over Keratoacanthoma (KA). The problem statement itself is to be validated first.\n\n**Validation of the Problem Statement**\n\n**Step 1: Extract Givens**\n- **Clinical context:** A rapidly growing, crateriform nodule on the dorsal forearm of a patient aged $72$ years with chronic ultraviolet exposure.\n- **Biopsy findings:** Cup-shaped epidermal invagination with a central keratin plug, flanked by acanthotic squamous epithelium. Dermal component shows well-differentiated squamous lobules with abundant keratinization.\n- **Diagnostic dilemma:** Keratoacanthoma (KA) versus conventional Squamous Cell Carcinoma (SCC).\n- **Guiding principles of malignancy (provided):**\n    1. Invasive growth beyond normal tissue planes.\n    2. High-grade cytologic atypia with atypical mitoses.\n    3. Invasion of neurovascular structures.\n- **Question:** Identify which features mandate a diagnosis of conventional SCC rather than KA.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientifically Grounded:** The problem is firmly rooted in the principles of dermatopathology. The distinction between KA and SCC is a well-established, albeit complex, area of study. The clinical presentation and histopathological description are classic for a lesion in the KA/SCC spectrum. The provided principles of malignancy (invasive growth, high-grade atypia, neurovascular invasion) are fundamental criteria used in cancer diagnosis across all fields of pathology. The problem is scientifically sound.\n- **Well-Posed:** The question is structured to have a definitive answer based on the provided principles and established diagnostic criteria in pathology. It asks for features that *mandate* an SCC diagnosis, which directs the solver to identify unequivocal, high-risk features. The problem is well-posed.\n- **Objective:** The language is technical, precise, and devoid of subjectivity. Terms like \"crateriform,\" \"acanthotic,\" \"cytologic atypia,\" and \"perineural invasion\" are standard, objective descriptors in pathology.\n\n**Step 3: Verdict and Action**\nThe problem statement is valid. It is scientifically sound, well-posed, objective, and provides a sufficient basis for a rigorous answer. I will now proceed with the solution.\n\n**Derivation and Option Analysis**\n\nThe task is to identify features that are incompatible with a diagnosis of Keratoacanthoma (KA) and instead are definitive for conventional Squamous Cell Carcinoma (SCC), using the given fundamental principles of malignancy. While KA is often considered a subtype of well-differentiated SCC, for the purpose of this question, we distinguish \"classic KA\" features from unequivocal SCC features.\n\n**A. Symmetric crateriform architecture with central keratin plug and broad pushing borders confined to the upper dermis**\nThis statement describes the archetypal features of a classic keratoacanthoma. Symmetry, a central keratin-filled crater, and \"broad pushing borders\" are the opposite of the infiltrative growth characteristic of a more aggressive SCC. Confinement to the upper dermis also argues against deep, aggressive invasion. These features would strongly favor a diagnosis of KA, not SCC.\n**Verdict: Incorrect.**\n\n**B. Irregular infiltrative tongues and strands of atypical squamous cells extending into deep dermis or subcutis, accompanied by a desmoplastic stromal response**\nThis description directly aligns with the first principle of malignancy: \"invasive growth beyond normal tissue planes.\" \"Irregular infiltrative tongues\" and extension into the \"deep dermis or subcutis\" are hallmark features of invasive SCC. A \"desmoplastic stromal response\" is the formation of fibrous tissue in response to tumor invasion, another indicator of aggressive behavior. These features are fundamentally inconsistent with the circumscribed nature of a classic KA.\n**Verdict: Correct.**\n\n**C. Marked cytologic atypia with numerous atypical mitoses and foci of tumor necrosis within invasive nests**\nThis statement relates to the second principle: \"high-grade cytologic atypia with atypical mitoses.\" While KA can exhibit some atypia, \"marked\" atypia, and especially \"numerous atypical mitoses\" (e.g., tripolar or bizarre forms), are definitive signs of high-grade malignancy characteristic of SCC. Spontaneous necrosis can be found in the keratin plug of a KA, but \"foci of tumor necrosis within invasive nests\" suggests that the tumor is outgrowing its blood supply, a feature of aggressive cancer. These findings mandate a diagnosis of SCC.\n**Verdict: Correct.**\n\n**D. Perineural invasion (tumor cells tracking along or within nerve sheaths) by atypical squamous nests**\nThis is a specific example of the third principle: \"invasion of neurovascular structures.\" Perineural invasion (PNI) is a well-established high-risk feature for SCC. It is a direct sign of local tissue invasion and is associated with a significantly higher risk of recurrence and metastasis. PNI is not a feature of classic KA. Its presence is an unambiguous indicator of malignancy and mandates a diagnosis of SCC.\n**Verdict: Correct.**\n\n**E. Intraepidermal neutrophils and focal microabscesses within the keratin plug, with otherwise well-circumscribed architecture**\nThe presence of neutrophils and microabscesses is a very common finding in the inflammatory infiltrate of a KA, often attracted by the large volume of keratin. The qualifier \"with otherwise well-circumscribed architecture\" further supports this being a feature of KA. This inflammatory response does not mandate a diagnosis of SCC.\n**Verdict: Incorrect.**\n\n**F. Abrupt keratinization with “glassy” eosinophilic cytoplasm in a well-demarcated lesion limited to the upper dermis**\nThis describes the classic cytological features of the squamous cells within a KA. The abundant, dense, \"glassy\" eosinophilic cytoplasm is a result of rapid and abrupt keratinization. The terms \"well-demarcated\" and \"limited to the upper dermis\" reinforce the classic KA pattern. This description favors KA, not SCC.\n**Verdict: Incorrect.**\n\n**G. Lymphovascular invasion (tumor cells within endothelial-lined spaces) by malignant squamous cells**\nThis is another specific example of the third principle: \"invasion of neurovascular structures.\" The presence of tumor cells within lymphatic or blood vessels is a direct route for metastasis. Lymphovascular invasion (LVI) is an unequivocal feature of malignancy and is associated with a poor prognosis. It is incompatible with the concept of a classic KA, even one considered a variant of SCC. The presence of LVI mandates a diagnosis of SCC.\n**Verdict: Correct.**\n\n**H. Clinical course of rapid growth followed by partial spontaneous regression and fibrosis at the lesion base without high-grade atypia or invasion**\nThis describes the classic clinical history and involutional stage of a KA. Rapid growth followed by spontaneous regression is the natural history that originally defined KA as a distinct entity. The corresponding histology of fibrosis at the base, combined with the stated absence of \"high-grade atypia or invasion,\" points directly to a diagnosis of KA, not SCC.\n**Verdict: Incorrect.**", "answer": "$$\\boxed{BCDG}$$", "id": "4450312"}, {"introduction": "Building on general diagnostic criteria, this practice delves into a specific, high-stakes finding: the proximity of tumor cells to nerves. You will learn to distinguish true perineural invasion (PNI), a marker of aggressive behavior, from benign perineural entrapment, a distinction that is vital for accurate prognostication and for guiding decisions on margin-controlled surgery and adjuvant therapy [@problem_id:4450287].", "problem": "A $72$-year-old man presents with a $7$-week history of a rapidly enlarging, dome-shaped nodule with a central keratin plug on the lateral cheek. Shave biopsy demonstrates a symmetrical, crateriform architecture with a buttressing epidermis and large lobules of glassy, eosinophilic keratinocytes with a pushing lower border. Within the deep dermis, a small-caliber nerve is seen adjacent to tumor nests. On immunohistochemistry, S$100$ highlights the nerve, cytokeratin highlights the epithelial tumor cells, and epithelial membrane antigen (EMA) outlines a continuous perineurial rim. The measured outer nerve diameter at this focus is $0.07\\ \\mathrm{mm}$. The patient has no pain, paresthesia, or motor deficits.\n\nUsing definitions of true perineural invasion and principles of dermatopathology, select all statements that correctly distinguish perineural pseudo-invasion from true perineural invasion in keratoacanthoma and appropriately connect these distinctions to diagnostic interpretation and prognostic/management implications.\n\nA. True perineural invasion is established when tumor cells are demonstrably within the perineurial space or endoneurium on routine histology, corroborated by immunohistochemistry showing breach of the EMA-positive perineurial rim by cytokeratin-positive cells; involvement of a large-caliber nerve with diameter $\\ge 0.1\\ \\mathrm{mm}$ is associated with increased risk of local recurrence and justifies margin-controlled excision (e.g., Mohs micrographic surgery) and consideration of adjuvant radiotherapy.\n\nB. Perineural pseudo-invasion in keratoacanthoma reflects entrapment of pre-existing dermal nerves at the pushing tumor border without breach of the perineurium; S$100$ highlights the nerve and EMA highlights a continuous perineurial sheath separating it from cytokeratin-positive tumor, and absent other high-risk features, complete excision with margin assessment and routine follow-up is appropriate.\n\nC. Any proximity of tumor cells within $\\le 0.05\\ \\mathrm{mm}$ of a nerve qualifies as true perineural invasion and mandates adjuvant radiotherapy regardless of other features.\n\nD. Neurologic symptoms (pain, paresthesia, motor deficit) are neither necessary nor sufficient to define histologic perineural invasion; they indicate clinical perineural involvement, but histologic criteria must demonstrate tumor within nerve sheaths to diagnose true perineural invasion, and their absence does not exclude it.\n\nE. In keratoacanthoma, perineural pseudo-invasion does not occur; any observation of tumor adjacent to a nerve implies progression to invasive squamous cell carcinoma, warranting aggressive therapy irrespective of histologic sheath integrity.\n\nAssume the standard dermatopathology definitions of perineural anatomy and the use of immunohistochemical markers (S$100$ for nerve, EMA for perineurium, cytokeratin for epithelium). When comparing the prognostic significance of perineural involvement, consider the established observation that large-caliber nerve involvement (diameter $\\ge 0.1\\ \\mathrm{mm}$) is associated with worse outcomes than small-caliber, incidental findings.", "solution": "The problem statement is found to be valid. It is scientifically grounded in established principles of dermatopathology, well-posed, and objective. The provided clinical and histopathological information constitutes a coherent and realistic case for evaluating the concepts of perineural invasion in the context of keratoacanthoma.\n\nThe core of the problem is to distinguish true perineural invasion (PNI) from perineural pseudo-invasion (also known as impingement or entrapment) and to understand the diagnostic, prognostic, and therapeutic implications of each.\n\n**Fundamental Principles**\n\n1.  **Perineural Anatomy and Immunohistochemistry (IHC):** A peripheral nerve fascicle, containing axons and Schwann cells, is enclosed by a specialized sheath called the perineurium.\n    *   **S$100$ protein** is a marker for cells of neural crest origin, including Schwann cells, and thus highlights the nerve fibers themselves.\n    *   **Epithelial Membrane Antigen (EMA)** is a marker for perineurial cells, thus outlining the perineurial sheath.\n    *   **Cytokeratins (CK)** are markers for epithelial cells, and thus highlight the tumor cells of a keratoacanthoma (KA) or squamous cell carcinoma (SCC).\n\n2.  **True Perineural Invasion (PNI):** PNI is a pathway of tumor dissemination and is defined by the presence of tumor cells **within any of the layers of the nerve sheath (epineurium, perineurium, or endoneurium)**. The most specific and diagnostically definitive criterion is the identification of tumor cells within the perineurial space, in direct contact with the endoneurium (the contents of the fascicle). Using IHC, this is demonstrated by finding CK-positive tumor cells internal to, or breaching, the EMA-positive perineurial rim. True PNI is a significant adverse prognostic factor, increasing the risk of local recurrence and metastasis. The risk is further stratified by the size of the nerve involved; invasion of a large-caliber nerve (generally defined as having a diameter $\\ge 0.1\\ \\mathrm{mm}$) is considered a high-risk feature. Management for high-risk PNI often involves margin-controlled excision (e.g., Mohs micrographic surgery) and may include adjuvant radiotherapy.\n\n3.  **Perineural Pseudo-invasion:** This phenomenon is not true invasion. It occurs when an expansile, pushing tumor (such as a classic KA) envelops or entraps a pre-existing dermal nerve without breaching its structural layers. Histologically, tumor nests are seen abutting the nerve, but the nerve's architecture is preserved. The key diagnostic feature, confirmed with IHC, is a continuous, intact EMA-positive perineurial sheath that completely separates the CK-positive tumor cells from the S$100$-positive nerve fibers. Perineural pseudo-invasion does not carry the adverse prognosis of true PNI and, in the absence of other high-risk features, does not typically alter the standard management of complete excision.\n\n4.  **Clinical Correlation:** Neurologic symptoms (e.g., pain, paresthesia) suggest clinical perineural involvement and are highly concerning for extensive PNI. However, PNI is ultimately a **histopathologic diagnosis**. Microscopic PNI, especially of small nerves, is very often asymptomatic. Therefore, the absence of symptoms does not exclude PNI. The given case demonstrates this, with no symptoms but with tumor adjacent to a nerve.\n\nThe presented case describes a KA with a pushing border, adjacent to a small-caliber nerve ($0.07\\ \\mathrm{mm} < 0.1\\ \\mathrm{mm}$) that displays a continuous EMA-positive perineurial rim. These findings are the classic definition of perineural pseudo-invasion.\n\n**Option-by-Option Analysis**\n\n**A. True perineural invasion is established when tumor cells are demonstrably within the perineurial space or endoneurium on routine histology, corroborated by immunohistochemistry showing breach of the EMA-positive perineurial rim by cytokeratin-positive cells; involvement of a large-caliber nerve with diameter $\\ge 0.1\\ \\mathrm{mm}$ is associated with increased risk of local recurrence and justifies margin-controlled excision (e.g., Mohs micrographic surgery) and consideration of adjuvant radiotherapy.**\nThis statement provides an accurate definition of true PNI, both histologically (\"within the perineurial space or endoneurium\") and with respect to IHC (\"breach of the EMA-positive perineurial rim\"). It correctly identifies the involvement of a large-caliber nerve (diameter $\\ge 0.1\\ \\mathrm{mm}$) as a high-risk prognostic factor and notes the appropriate corresponding management considerations (margin-controlled excision, possible adjuvant radiotherapy). This aligns perfectly with modern dermatopathology and oncology guidelines.\n**Verdict: Correct**\n\n**B. Perineural pseudo-invasion in keratoacanthoma reflects entrapment of pre-existing dermal nerves at the pushing tumor border without breach of the perineurium; S$100$ highlights the nerve and EMA highlights a continuous perineurial sheath separating it from cytokeratin-positive tumor, and absent other high-risk features, complete excision with margin assessment and routine follow-up is appropriate.**\nThis statement accurately describes perineural pseudo-invasion as an entrapment phenomenon characteristic of tumors with pushing borders, like KA. It correctly identifies the key IHC finding: an intact EMA-positive perineurium separating the tumor (CK-positive) from the nerve (S$100$-positive). Furthermore, it correctly states the management implication: that this finding alone does not warrant aggressive therapy beyond standard complete excision, as it is not an independent high-risk feature.\n**Verdict: Correct**\n\n**C. Any proximity of tumor cells within $\\le 0.05\\ \\mathrm{mm}$ of a nerve qualifies as true perineural invasion and mandates adjuvant radiotherapy regardless of other features.**\nThis statement is fundamentally flawed. True PNI is defined by invasion *into* the nerve sheath, not mere proximity. A tumor can be in direct contact with a nerve without invading it. The distance threshold of $\\le 0.05\\ \\mathrm{mm}$ is an arbitrary value not used in the standard definition of PNI. Finally, mandating adjuvant radiotherapy based on proximity alone, irrespective of other critical factors like nerve size, margin status, or true invasion, is contrary to established clinical practice.\n**Verdict: Incorrect**\n\n**D. Neurologic symptoms (pain, paresthesia, motor deficit) are neither necessary nor sufficient to define histologic perineural invasion; they indicate clinical perineural involvement, but histologic criteria must demonstrate tumor within nerve sheaths to diagnose true perineural invasion, and their absence does not exclude it.**\nThis statement correctly articulates the relationship between clinical findings and histopathologic diagnosis. PNI is a microscopic finding that is often asymptomatic (\"not necessary\"). Symptoms alone are not diagnostic; they must be confirmed by biopsy (\"not sufficient\"). The statement correctly emphasizes that the definitive diagnosis rests on histologic criteria and that asymptomatic patients can still have microscopically-proven PNI.\n**Verdict: Correct**\n\n**E. In keratoacanthoma, perineural pseudo-invasion does not occur; any observation of tumor adjacent to a nerve implies progression to invasive squamous cell carcinoma, warranting aggressive therapy irrespective of histologic sheath integrity.**\nThis statement is factually incorrect. Perineural pseudo-invasion is a well-recognized phenomenon, particularly in tumors with expansile growth patterns like KA. To claim it \"does not occur\" is false. Furthermore, it incorrectly asserts that any tumor-nerve adjacency signifies aggressive transformation and warrants aggressive therapy while disregarding the crucial diagnostic role of \"histologic sheath integrity.\" The distinction between an intact and a breached sheath is the very basis for differentiating low-risk pseudo-invasion from high-risk true invasion.\n**Verdict: Incorrect**", "answer": "$$\\boxed{ABD}$$", "id": "4450287"}, {"introduction": "Effective patient care extends far beyond the initial diagnosis and excision, as keratoacanthomas mark a patient at high risk for future skin cancers due to field cancerization. This practice challenges you to synthesize principles from wound healing, oncologic surveillance, and preventive medicine to construct a comprehensive, evidence-based follow-up plan [@problem_id:4450244].", "problem": "A $68$-year-old immunocompetent man with extensive actinic damage presents after complete elliptical excision of a rapidly growing crateriform nodule on the dorsal forearm. Histopathology reports a keratoacanthoma-type well-differentiated squamous cell carcinoma (SCC) with clear peripheral and deep margins, no perineural invasion, and no high-risk features. He seeks guidance on postoperative care and follow-up. Using fundamental facts about wound healing kinetics, tumor biology of keratinocyte carcinomas, and photobiology of ultraviolet (UV) radiation, select the most appropriate structured follow-up plan that integrates: timing of wound checks and suture removal, recurrence/new primary surveillance intervals, and patient education on UV protection and self-surveillance.\n\nWhich option best reflects a scientifically grounded plan?\n\nA. Schedule suture removal at $10$–$14$ days for a forearm excision, with earlier review only if signs of complications (bleeding, dehiscence, infection) arise; provide written wound care instructions (non-adherent dressing, gentle cleansing after $24$–$48$ hours, petrolatum, activity restriction to reduce tension); arrange a clinic review at $4$–$6$ weeks for scar assessment; institute full-body skin examination every $3$–$6$ months for $2$ years, then annually thereafter; teach monthly self–skin examinations; counsel comprehensive UV protection: daily broad-spectrum sunscreen Sun Protection Factor (SPF) $\\ge 30$ with reapplication every $\\approx 2$ hours and after swimming/sweating, Ultraviolet Protection Factor (UPF) $\\ge 50$ clothing and wide-brimmed hats, shade seeking from $10$ am to $4$ pm, and strict avoidance of tanning devices; discuss oral nicotinamide $500$ mg twice daily only if the patient has a history of multiple ($\\ge 2$) prior keratinocyte carcinomas, and consider field therapy for actinic keratoses as indicated.\n\nB. No scheduled postoperative follow-up is required after clear margins; suture removal at $3$–$4$ days is acceptable; advise sunscreen SPF $15$ use only during summer or on high UV index days; surveillance can be deferred unless the patient notices regrowth at the excision site.\n\nC. Daily wound checks in clinic for the first week with suture removal at $3$ days to minimize scarring; annual full-body skin examination starting immediately; encourage short midday sun exposure for vitamin D synthesis and reserve sunscreen for beach vacations; advise self–skin examinations only if new symptoms occur.\n\nD. Suture removal at $10$–$14$ days followed by indefinite $3$-monthly reviews with baseline lymph node ultrasound despite low-risk histology; discourage routine sunscreen use due to potential chemical exposure; recommend gradual tanning (including tanning beds) after wound healing to increase cutaneous resilience; begin systemic retinoid chemoprophylaxis in all patients post–keratoacanthoma excision.", "solution": "The reasoning proceeds from foundational biological and clinical principles.\n\nFirst, consider wound healing kinetics and the biomechanics of suture removal. Cutaneous wound healing follows phases: hemostasis and inflammation (approximately $0$–$3$ days), proliferation (approximately $3$–$14$ days) with re-epithelialization, granulation tissue formation, and collagen deposition, and remodeling thereafter. Early tensile strength is limited, and removal of sutures before sufficient collagen maturation in high-tension sites (such as the forearm) increases the risk of dehiscence. Empirically, extremity excisions commonly require suture removal at approximately $10$–$14$ days to balance dehiscence risk and scar quality. Routine daily early clinic visits are unnecessary for uncomplicated wounds; instead, patients should receive clear instructions for signs of complications (bleeding, infection, dehiscence) and wound care (gentle cleansing after $24$–$48$ hours, petrolatum to maintain a moist environment, appropriate non-adherent dressings, and activity restriction to decrease tension).\n\nSecond, integrate tumor biology and recurrence/new primary surveillance. Keratoacanthoma is conventionally managed as a variant of SCC due to diagnostic overlap and the potential for local tissue destruction. When completely excised with clear margins and absent high-risk features (e.g., perineural invasion, poor differentiation, large size, deeply invasive disease, immunosuppression), the risk of local recurrence is low. However, the patient has field cancerization from chronic UV exposure, elevating the risk for future keratinocyte carcinomas (both SCC and basal cell carcinoma). Evidence-based surveillance for low- to intermediate-risk cutaneous SCC typically recommends full-body skin examinations every $3$–$6$ months for the first $2$ years (the period of highest recurrence or second primary incidence), then annually. Self–skin examination monthly improves early detection.\n\nThird, photobiology underpins UV protection. Ultraviolet radiation (UV; encompassing Ultraviolet A and Ultraviolet B) induces DNA photoproducts (e.g., cyclobutane pyrimidine dimers), mutagenizes tumor suppressor pathways (e.g., $p53$), and causes local immunosuppression. Broad-spectrum sunscreen with SPF $\\ge 30$ reduces erythema and cumulative DNA damage; reapplication every $\\approx 2$ hours and after water/sweat exposure is essential due to photodegradation and physical removal. UPF-rated clothing (UPF $\\ge 50$), wide-brim hats, shade seeking particularly between $10$ am and $4$ pm, and avoidance of artificial UV (tanning beds) are core measures. Advising intentional midday sun exposure prioritizes vitamin D at the expense of carcinogenesis and is not appropriate in this context.\n\nFinally, chemoprevention should be selective. Oral nicotinamide $500$ mg twice daily has been shown to reduce the incidence of new keratinocyte carcinomas in high-risk individuals (e.g., those with multiple prior non-melanoma skin cancers), by enhancing DNA repair and mitigating UV-induced immunosuppression. It is not routinely indicated for all post–keratoacanthoma patients without a history of multiple cancers. Systemic retinoids are reserved for select very high-risk cohorts (e.g., solid organ transplant recipients with numerous aggressive SCCs) due to adverse effects.\n\nOption-by-option analysis:\n\nA. This plan aligns with wound healing biomechanics (suture removal at $10$–$14$ days on the forearm, with contingency for earlier review only if complications arise), provides realistic wound care steps, and includes a pragmatic $4$–$6$ week scar assessment. The surveillance schedule (every $3$–$6$ months for $2$ years, then annually) fits low-risk SCC/keratoacanthoma management while acknowledging field cancerization. Monthly self-exams are appropriate. UV education is comprehensive and accurate: broad-spectrum SPF $\\ge 30$ with reapplication every $\\approx 2$ hours, UPF $\\ge 50$ clothing, shade $10$ am–$4$ pm, and avoidance of tanning devices. Nicotinamide is correctly framed for patients with multiple ($\\ge 2$) prior keratinocyte carcinomas rather than universally prescribed. Field therapy consideration for actinic keratoses accords with the concept of field cancerization. Verdict: Correct.\n\nB. This plan underestimates wound maturation (suture removal at $3$–$4$ days on the forearm is too early, risking dehiscence) and neglects scheduled surveillance despite field cancerization. SPF $15$ and conditional use only during high UV index days is insufficient. Deferring follow-up until visible regrowth misses the window for detecting new primaries and subclinical recurrences. Verdict: Incorrect.\n\nC. Daily clinic wound checks are unnecessary for an uncomplicated excision and impose undue burden; suture removal at $3$ days is premature for a forearm wound. Annual-only surveillance is too sparse in the first $2$ years. Encouraging midday sun for vitamin D contradicts photobiology evidence and increases carcinogenesis risk. Reserving sunscreen for vacations is inappropriate given chronic UV exposure. Verdict: Incorrect.\n\nD. While suture removal timing is reasonable, indefinite $3$-monthly review with baseline lymph node ultrasound is excessive and not evidence-based for low-risk, completely excised keratoacanthoma-type SCC; routine imaging is not indicated. Discouraging sunscreen and promoting tanning (including tanning beds) is contraindicated. Universal systemic retinoids post-excision are unwarranted and expose patients to unnecessary toxicity. Verdict: Incorrect.", "answer": "$$\\boxed{A}$$", "id": "4450244"}]}